GenScript

GenScript Biotech Corporation is a global biotechnology company founded in 2002 in New Jersey, USA. It specializes in life science services and products that support innovation in biotech, healthcare, and pharmaceuticals. The company is publicly traded on the Hong Kong Stock Exchange and reported USD 358.5 million in revenue for the fiscal year ending December 31, 2022, reflecting a 12% year-over-year growth. GenScript began as a pioneer in custom gene synthesis and has expanded its offerings to include peptide synthesis, protein production, antibody development, and synthetic biology products. The company operates through its Life Science Group, providing services such as gene and DNA synthesis, CRISPR services, and life-science equipment. GenScript serves over 100,000 researchers globally, including those in academia and major pharmaceutical companies, and is recognized for its fast turnaround, high quality, and reliable support.